Baylor Genetics

Baylor Genetics Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at

Baylor Genetics is founded in academics and driven by discovery; we are dedicated to delivering comprehensive answers to the toughest genetic questions.

Meet Autri Dutta, VP of Emerging Products at Baylor Genetics. Autri leads Emerging Products across four areas: data and ...
09/03/2026

Meet Autri Dutta, VP of Emerging Products at Baylor Genetics.

Autri leads Emerging Products across four areas: data and informatics, newborn screening and population genomics, biopharma, and AI. His focus is what our clinical genomics data can become beyond the diagnostic report: the population-scale programs, and the partnerships that put genomic answers to work.

Autri brings more than 20 years of product leadership at organizations including Roche and Philips, where his focus was turning raw genomic data into clinical intelligence physicians can act on.

We're proud to have Autri on our team and appreciate the insight and leadership he brings every day.

Learn more about our team: https://www.baylorgenetics.com/people/

September is Newborn Screening (NBS) Awareness Month. NBS is a cornerstone of pediatric care that helps detect serious h...
09/02/2026

September is Newborn Screening (NBS) Awareness Month.

NBS is a cornerstone of pediatric care that helps detect serious health conditions often before symptoms appear. However, traditional NBS cannot detect all genetic conditions.

Baylor Genetics’ Whole Genome Sequencing, Whole Exome Sequencing, and Global MAPS® build on the principles behind NBS by offering comprehensive genomics and metabolomics analysis. These tools support earlier and more precise diagnoses by identifying a broader range of genetic conditions than routine newborn screening, potentially improving outcomes for the most vulnerable patients.

Learn more: www.baylorgenetics.com/whole-genome-sequencing/

Nearly one-third of babies with suspected genetic conditions may face life-threatening complications before a diagnosis ...
09/01/2026

Nearly one-third of babies with suspected genetic conditions may face life-threatening complications before a diagnosis is made.

In the NICU, every moment matters. Rapid genomic testing can help uncover answers sooner, supporting timely diagnoses and informed care decisions for critically ill infants.

Our Rapid Whole Genome Sequencing (rWGS) as a first-tier test for infants and children in the NICU/PICU can accelerate diagnosis with superior yield. Comprehensive written results are available in 5 days.

Learn more about how Baylor Genetics' rWGS can help shorten hospital stays and facilitate discharge with a clear diagnosis: www.baylorgenetics.com/whole-genome-sequencing/

Meet Jessica Profato-Partlow, VP of Product Management at Baylor Genetics.With more than a decade of experience in oncol...
08/28/2026

Meet Jessica Profato-Partlow, VP of Product Management at Baylor Genetics.

With more than a decade of experience in oncology and multi-cancer diagnostics, Jessica leads Product Management with a focus on connecting product innovation, clinical strategy, and business priorities. Her expertise launching innovative diagnostic solutions and building high-performing teams helps ensure our products continue to meet the evolving needs of providers and patients.

Jessica’s collaborative approach strengthens partnerships across clinical and commercial leadership, helping turn scientific innovation into meaningful healthcare impact.

Learn more about our team: https://www.baylorgenetics.com/people/

08/26/2026

Genome sequencing is transforming how we support patients throughout pregnancy.

Dr. April Adams of Baylor College of Medicine discusses how genome sequencing can provide answers for women living with genetic conditions. The technology can also provide earlier insight into fetal anomalies prior to delivery and support more informed decision-making at critical moments in care.

Learn how genome sequencing can help deliver more timely, confident answers for patients and providers: www.baylorgenetics.com

We connected with customers and partners at our Whole Genome Sequencing (WGS) education dinner in Miami to discuss the e...
08/21/2026

We connected with customers and partners at our Whole Genome Sequencing (WGS) education dinner in Miami to discuss the evolving role of comprehensive genomic testing.

Together, we explored how closing the diagnostic gap requires a comprehensive approach that builds on WGS with additional technologies like RNA Sequencing, optical genome mapping, and long-read sequencing to deliver deeper insight and clearer answers.

Thank you to everyone who joined us and contributed to an engaging discussion.

Learn how our integrated multiomic approach can support more informed clinical decisions and earlier answers for patients facing rare and complex conditions: www.baylorgenetics.com

Don't miss next week's webinar on the clinical impact of RNA sequencing in rare disease diagnostics. In a retrospective...
08/19/2026

Don't miss next week's webinar on the clinical impact of RNA sequencing in rare disease diagnostics.

In a retrospective analysis of more than 3,200 Whole Genome and Whole Exome Sequencing cases, targeted reflex RNA Sequencing led to variant reclassification in 42% of completed cases, demonstrating its potential to uncover clinically meaningful findings beyond genome sequencing alone.

Join Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer at Baylor Genetics, for the GenomeWeb-hosted webinar, When Genome isn't Enough: Closing Rare Disease Gaps with RNA Sequencing, to learn more.

Register today: https://bit.ly/4bNfv9n

08/17/2026

Many patients with suspected rare genetic diseases remain undiagnosed after genome sequencing, often due to variants of uncertain significance.

Join Christine Eng, MD, Chief Medical Officer and Chief Quality Officer at Baylor Genetics, for the GenomeWeb-hosted webinar, When the Genome isn't Enough: Closing Rare Disease Gaps with RNA Sequencing (RNA-Seq).

Drawing on Baylor Genetics' experience with targeted reflex RNA-Seq, Dr. Eng will discuss how this approach can help resolve uncertain findings, uncover additional diagnoses, and inform patient care.

Register today: https://bit.ly/4gajhvT

08/17/2026

Not all genetic findings are linked to disease risk, but some can have important implications beyond medication response.

In this video, Lauren Marcath, PharmD, discusses why conversations between patients and their healthcare providers about the results of pharmacogenomic testing are essential.

Our research found that approximately 1 in 7 patients had findings with implications beyond how medications are prescribed, highlighting the value of understanding results in the context of an individual's overall health and disease risk

Targeted reflex RNA sequencing can uncover answers beyond the genome.In a retrospective analysis of more than 3,200 whol...
08/12/2026

Targeted reflex RNA sequencing can uncover answers beyond the genome.

In a retrospective analysis of more than 3,200 whole genome and whole exome sequencing cases, RNA sequencing led to variant reclassification in 42.2% of completed cases, resulting in a genetic or likely genetic diagnosis for 25 patients. Among cases with positive RNA-seq results, clinical management changed in 71% of cases, underscoring its potential clinical impact.

Join Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer, for the GenomeWeb-hosted webinar, When Genome Isn't Enough: Closing Rare Disease Gaps with RNA Sequencing, to learn how RNA sequencing can help improve diagnostic outcomes.

Register today: https://bit.ly/4bNfv9n

Address

2450 Holcombe Boulevard
Houston, TX
77021

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm
Saturday 8am - 6pm

Telephone

+18004114363

Website

Alerts

Be the first to know and let us send you an email when Baylor Genetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category